By Professor Emad El-Omar

Books

El-Omar EM, 2012, Foreword, http://dx.doi.org/10.1142/9789814343602_fmatter

Book Chapters

Chew DCH; Yim CHH; Ali RAR; El‐Omar EM, 2024, 'Epidemiology, Microbiome, and Risk Factors Involved in Carcinogenesis of Esophagus, Gastric, and Intestine', in , Wiley, pp. 2 - 22, http://dx.doi.org/10.1002/9781119756422.ch1

Hsin Chew DC; Howard Yim CH; Ali RAR; El-Omar EM, 2024, 'Epidemiology, Microbiome, and Risk Factors Involved in Carcinogenesis of Esophagus, Gastric, and Intestine', in Jankowski JAZ (ed.), Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach, Wiley, pp. 3 - 22, http://dx.doi.org/10.1002/9781119756422.ch1

Muhammad Nawawi KN; El-Omar EM; Ali RAR, 2024, 'Screening, Surveillance, and Prevention of Esophageal and Gastric Cancers', in Jankowski JAZ (ed.), Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach, Wiley, pp. 42 - 62, http://dx.doi.org/10.1002/9781119756422.ch3

El‐Omar EM; Yim H, 2022, 'Tumors of the stomach', in , Wiley, pp. 1023 - 1046, http://dx.doi.org/10.1002/9781119600206.ch52

Craig PI; El-Omar EM, 2022, 'Tumors of the stomach', in Yamada S Atlas of Gastroenterology Sixth Edition, pp. 170 - 176, http://dx.doi.org/10.1002/9781119600527.ch19

Angus BJ; Anstee QM; Burnett L; Byers M; Campbell H; Clunie GPR; Colvin LA; Conway B; Cooper N; Cracknell AL; Culligan DJ; Dark GG; Davenport RJ; Dockrell DH; El-Omar E; Fallon M; FitzPatrick DR; Grubb NR; Ibbotson SH; Innes JA; Jenks SJ; Johnston SL; Jones DEJ; Langhorne P; Lawrie SM; Leach JP; Maartens G; Mackillop L; MacMahon MJ; Mann R; Manson LM; Marshall SE; Mather A; Maxwell SR; McAllister DA; McCrimmon RJ; McLean M; Neuberger FEM; Newby DE; Newell-Price JDC; Olson J; Pearson ER; Phelan PJ; Ralston SH; Reid PT; Sandoe JAT; Scott GR; Shand AG; Steel RM; Stewart GD; Stewart P; Strachan MWJ; Sullivan DR; Sundar S; Tallentire VR; Tatton-Brown K; Thomas SHL; Watson HG; White J; Wilding JPH; Witham MD, 2022, 'Participants aux Davidson's Principles and Practice of Medicine, 23eédition', in Davidson : L'essentiel de la Médecine, Elsevier, pp. ix - xiv, http://dx.doi.org/10.1016/b978-2-294-77556-7.09990-2

El-Assaad F; Gong L; Gia A; Yim H; El-Omar E, 2019, 'Helicobacter pylori, peptic ulcer disease and gastric cancer', in Eslick G (ed.), Gastrointestinal Diseases and Their Associated Infections, Elsevier, St Louis, pp. 17 - 29, http://dx.doi.org/10.1016/b978-0-323-54843-4.00002-7

Wong MYW; El-Omar E, 2019, 'Connective Tissue Disorders, Gastrointestinal Tract Manifestations of', in Encyclopedia of Gastroenterology Second Edition, pp. 727 - 733, http://dx.doi.org/10.1016/B978-0-12-801238-3.65658-1

Wong MY; El-Omar E, 2019, 'Connective Tissue Disorders, Gastrointestinal Tract Manifestations of', in Encyclopedia of Gastroenterology, pp. Vol1 - V733, http://dx.doi.org/10.1016/B978-0-12-801238-3.65658-1

Wu N; Yim HCH; Grimm M; El-Omar E, 2019, 'Epithelial Barrier Function', in Encyclopedia of Gastroenterology Second Edition, pp. 300 - 313, http://dx.doi.org/10.1016/B978-0-12-801238-3.65657-X

Wu N; Yim HCH; Grimm M; El-Omar E, 2019, 'Epithelial Barrier Function', in Encyclopedia of Gastroenterology, pp. Vol2 - V313, http://dx.doi.org/10.1016/B978-0-12-801238-3.65657-X

Wong MYW; El-Omar E, 2019, 'Vasculitis, Gastrointestinal Manifestations of', in Encyclopedia of Gastroenterology Second Edition, pp. 700 - 706, http://dx.doi.org/10.1016/B978-0-12-801238-3.65670-2

Wong MY; El-Omar E, 2019, 'Vasculitis, Gastrointestinal Manifestations of', in Encyclopedia of Gastroenterology, pp. Vol4 - V706, http://dx.doi.org/10.1016/B978-0-12-801238-3.65670-2

El-Assaad F; Gong L; Gia A; Yim HCH; El-Omar EM, 2019, 'Chapter 2 Helicobacter pylori, Peptic Ulcer Disease and Gastric Cancer', in Gastrointestinal Diseases and their Associated Infections, Elsevier, pp. 17 - 29, http://dx.doi.org/10.1016/b978-0-323-54843-4.00002-7

El-Omar EM; Wu CY, 2016, 'Tumors of the stomach', in Podolsky DK; Camilleri M; Fitz JG; Kalloo AN; Shanahan F; Wang TC (ed.), Yamada's Atlas of Gastroenterology, John Wiley & Sons, pp. 149 - 152

McLean MH; Nicoll R; Saw C; Hold GL; El-Omar EM, 2016, 'Influence of host gene polymorphisms on development of gastroduodenal diseases', in Helicobacter pylori Research: From Bench to Bedside, pp. 339 - 362, http://dx.doi.org/10.1007/978-4-431-55936-8_14

El-Omar EM; McLean MH, 2015, 'Tumors of the Stomach', in Yamada S Textbook of Gastroenterology Sixth Edition, pp. 1121 - 1140, http://dx.doi.org/10.1002/9781118512074.ch59

El-Omar EM, 2012, 'FROM INFLAMMATION TO CANCER Advances in Diagnosis and Therapy for Gastrointestinal and Hepatological Diseases Foreword', in Cho CH; Yu J (ed.), FROM INFLAMMATION TO CANCER: ADVANCES IN DIAGNOSIS AND THERAPY FOR GASTROINTESTINAL AND HEPATOLOGICAL DISEASES, WORLD SCIENTIFIC PUBL CO PTE LTD, pp. V - VI

El-Omar EM, 2009, 'Role of host genetic susceptibility in the pathogenesis of gastric cancer', in Biology of Gastric Cancers, pp. 235 - 250, http://dx.doi.org/10.1007/978-0-387-69182-4_9

McKinlay A; Park K; Gunasekera R; El-Omar EM, 2003, 'Gastric Cancer in the Elderly', in Interdisciplinary Topics in Gerontology, KARGER, pp. 145 - 156, http://dx.doi.org/10.1159/000072618

McColl KEL; Gillen D; ElOmar E; Oien K; Dahill S, 1996, 'Helicobacter pylori gastritis and gastric acid secretory function - An integrated approach', in Hunt RH; Tytgat GNJ (ed.), , SPRINGER, pp. 122 - 131

McColl KEL; El-Omar E, 1994, 'Effect of H. pylori infection on gastrin and gastric acid secretion', in Helicobacter pylori, Springer Netherlands, pp. 245 - 256, http://dx.doi.org/10.1007/978-94-011-1418-9_21

El-Omar EM, 'Analysis of Single Nucleotide Polymorphisms in the Interleukin-1B Gene Using 5' Nuclease Assays', in Interleukin Protocols, Humana Press, pp. 409 - 417, http://dx.doi.org/10.1385/1-59259-146-9:409

Journal articles

Lappin JM; Bolton P; Smith G; Chua XY; Grattan S; Samaras K; Day R; Popovic G; O'Donnell M; Buten S; Hansen J; Teasdale S; Wong T; El-Omar E, 2026, 'Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial', Schizophrenia Research, 296, pp. 19 - 28, http://dx.doi.org/10.1016/j.schres.2026.06.021

Wills OC; Chua XY; McEvoy C; Fitzmaurice M; El-Assaad F; El-Omar E; Probst Y, 2026, 'A case-control study of the oral microbiome among Australian female adults with relapsing-remitting multiple sclerosis: A pilot study', Multiple Sclerosis and Related Disorders, 113, http://dx.doi.org/10.1016/j.msard.2026.107383

El-Assaad F; El-Omar EM, 2026, 'Gut-peritoneal-multisystem axis in endometriosis', Gut, 75, pp. 1085 - 1086, http://dx.doi.org/10.1136/gutjnl-2025-337490

Quansah M; David MA; Martins R; El-Omar E; Aliberti SM; Capunzo M; Jensen SO; Tayebi M, 2026, 'Correction: The Beneficial Effects of Lactobacillus Strains on Gut Microbiome in Alzheimer’s Disease: A Systematic Review (Healthcare, (2025), 13, 1, (74), 10.3390/healthcare13010074)', Healthcare Switzerland, 14, http://dx.doi.org/10.3390/healthcare14080974

El-Omar EM; Lyu G, 2026, 'eGastroenterology: a new chapter with exciting times ahead!', Egastroenterology, 4, http://dx.doi.org/10.1136/egastro-2026-100427

Wen W; Su R; Liu Y; Feng Z; Li Y; Li J; Huang Z; Zhang F; Gao S; Ma Y; Zhou Q; El-Omar EM; Barr JJ; Zuo T, 2026, 'Gut DNA virome enterotype dictates inflammation heterogeneity through tuning the phage-bacteria-sphingosine-intestine axis in Crohn's disease', Cell Host and Microbe, 34, pp. 460 - 478.e9, http://dx.doi.org/10.1016/j.chom.2026.01.016

Louca P; Manning S; Hackney E; Sharp L; Hull MA; Koo S; Young GR; Taylor GS; Dunneram Y; Mitra S; Hampton JS; Dobson C; Neilson LJ; Addison C; El-Omar EM; Stewart CJ; Rees CJ, 2026, 'Gut microbiome signatures in colorectal neoplasia: a cross-sectional study across neoplasia stages and subtypes', GUT, http://dx.doi.org/10.1136/gutjnl-2025-337478

Huang Z; Liu Y; Wu Y; Zhang F; Yu L; Gao S; Wen W; Wang G; Su R; Xia P; Zhou Q; Bie Y; Hu P; Burgermeister E; Lan P; Wu X; Zhang H; Zhang F; El-Omar EM; Zuo T, 2026, 'Gut mucosal mycobiome profiling in Crohn’s disease uncovers an AMP-mediated anti-inflammatory effect of Cladosporium sphaerospermum', Nature Metabolism, 8, pp. 389 - 409, http://dx.doi.org/10.1038/s42255-025-01420-9

Huang Z; Liu Y; Wu Y; Zhang F; Yu L; Gao S; Wen W; Wang G; Su R; Xia P; Zhou Q; Bie Y; Hu P; Burgermeister E; Lan P; Wu X; Zhang H; Zhang F; El-Omar EM; Zuo T, 2026, 'Publisher Correction: Gut mucosal mycobiome profiling in Crohn’s disease uncovers an AMP-mediated anti-inflammatory effect of Cladosporium sphaerospermum (Nature Metabolism, (2026), 10.1038/s42255-025-01420-9)', Nature Metabolism, 8, pp. 521, http://dx.doi.org/10.1038/s42255-026-01460-9

Lai CT; Lee WH; Chang YY; Chiu HM; Wu CY; Chou HC; Chen MJ; Ei-Omar EM, 2026, 'Concurrent evolution of infant oral and gut microbiota implies oral-to-gut transmission', Journal of the Formosan Medical Association, http://dx.doi.org/10.1016/j.jfma.2026.05.060

Sahran NF; Chong CW; Ismail IH; Taib F; Hoo PS; Palanisamy UD; Sundralingam U; Teh CSJ; Kong ZX; Ayub Q; Yoke Ling F; Hazlan SNH; Azlan M; Abdul Razak S; Tengku Din TADAA; Abdullah N; Tagiling N; Tee V; Ehab Ayad M; Zheng FM; El-Omar E; Lee YY, 2026, 'Effects of Traditional Asian Diet on dietary fibre requirement, gut microbiome composition, and faecal and urine metabolomes in healthy Asian women: a pilot study', Beneficial Microbes, 17, pp. 47 - 60, http://dx.doi.org/10.1163/18762891-BjA00074

Saleem N; Kumar N; El-Omar E; Willcox M; Jiang XT, 2026, 'Nano-antimicrobial peptides (Nano-AMPs) to combat resistant gram-negative bacteria', Drug Delivery and Translational Research, pp. 1 - 35, http://dx.doi.org/10.1007/s13346-026-02085-x

Blickisdorf T; Wood LG; Valkenborghs SR; Dixon AE; Horvat JC; Weaver NA; Yoong S; Berthon BS; Williams EJ; Brown AC; Jenkins CR; Morrissey ML; Wark PA; Wynne K; Grainge CL; El-Omar EM; Williams LM; Brannan JD; De Wang L; Wong SL; Scott HA, 2026, 'Personalising the management of obesity-related asthma using medical nutrition therapy and physical activity prescription: The IDEAL study protocol', Contemporary Clinical Trials, 160, http://dx.doi.org/10.1016/j.cct.2025.108178

Liou J-M; Chen M-J; Chen C-C; Fang Y-J; Chen P-Y; Lin J-T; El-Omar EM; Wu M-S, 2026, '1276 IDENTIFICATION OF THE OPTIMAL SCREENING STRATEGY FOR HELICOBACTER PYLORI INFECTION FOR GASTRIC CANCER PREVENTION: A MULTICENTER RANDOMIZED CONTROLLED TRIAL', Gastroenterology, 170, pp. S - 2535, http://dx.doi.org/10.1016/s0016-5085(26)06008-7

Liou J-M; Chen M-J; Chen C-C; Fang Y-J; Chen P-Y; Lin J-T; El-Omar EM; Wu M-S, 2026, '1276 IDENTIFICATION OF THE OPTIMAL SCREENING STRATEGY FOR HELICOBACTER PYLORI INFECTION FOR GASTRIC CANCER PREVENTION: A MULTICENTER RANDOMIZED CONTROLLED TRIAL', Gastrointestinal Endoscopy, 103, pp. S - 2535, http://dx.doi.org/10.1016/s0016-5107(26)05939-0

Liou J-M; Chen M-J; Chen P-Y; Chen C-C; Fang Y-J; Lin J-T; El-Omar EM; Wu M-S, 2026, '863 COMPARISON OF THE EFFICACY AND GUT MICROBIOTA IMPACT OF VONOPRAZAN-BASED VERSUS LANSOPRAZOLE-BASED REGIMENS FOR FIRST-LINE HELICOBACTER PYLORI TREATMENT: A MULTICENTER OPEN-LABEL RANDOMIZED CONTROLLED TRIAL', Gastrointestinal Endoscopy, 103, pp. S - 2521, http://dx.doi.org/10.1016/s0016-5107(26)05910-9

Liou J-M; Chen M-J; Chen P-Y; Chen C-C; Fang Y-J; Lin J-T; El-Omar EM; Wu M-S, 2026, '863 COMPARISON OF THE EFFICACY AND GUT MICROBIOTA IMPACT OF VONOPRAZAN-BASED VERSUS LANSOPRAZOLE-BASED REGIMENS FOR FIRST-LINE HELICOBACTER PYLORI TREATMENT: A MULTICENTER OPEN-LABEL RANDOMIZED CONTROLLED TRIAL', Gastroenterology, 170, pp. S - 2521, http://dx.doi.org/10.1016/s0016-5085(26)05979-2

Yuan L; Lan Z; Zhu J; Chen Y; Zhao Y; Wang N; Zheng H; Wan Z; Liu L; Sun J; El-Omar EM; Zhao Z; Li P, 2025, 'Combined impact of multiple healthy lifestyles on digestive diseases: a large population-based prospective cohort study', BMC Medicine, 23, http://dx.doi.org/10.1186/s12916-025-04485-1

Saleem N; Kumar N; El-Omar E; Willcox M; Jiang XT, 2025, 'Harnessing Machine Learning Approaches for the Identification, Characterization, and Optimization of Novel Antimicrobial Peptides', Antibiotics, 14, pp. 1263, http://dx.doi.org/10.3390/antibiotics14121263

El-Omar EM; Gill US; Rees CJ, 2025, 'Introducing Gut Science—a fundamental and discovery science companion journal to Gut', Gut, 74, pp. 1943 - 1944, http://dx.doi.org/10.1136/gutjnl-2025-337140

Black EG; Bugarcic A; Lauche R; El-Omar E; El-Assaad F, 2025, 'The Effects of Kefir on the Human Oral and Gut Microbiome', Nutrients, 17, http://dx.doi.org/10.3390/nu17243861

Liou JM; Malfertheiner P; Hong TC; Cheng HC; Sugano K; Shah S; Sheu BS; Chen MJ; Chiang TH; Chen YC; Yamaoka Y; Wong SH; Chen CC; Lee YY; Quach DT; Wu DC; Hsu PI; Wu CY; Wu JY; Luo JC; Chang WL; Lu H; Suzuki H; Jung HY; Mahachai V; Vilaichone RK; Mégraud F; Lin JT; Yeoh KG; Leung WK; El-Omar EM; Lee YC; Wu MS, 2025, 'Screening and eradication of Helicobacter pylori f or gastric cancer prevention: Taipei Global Consensus II', Gut, 74, pp. 1767 - 1791, http://dx.doi.org/10.1136/gutjnl-2025-336027

Li P; Xie L; Zheng H; Feng Y; Mai F; Tang W; Wang J; Lan Z; Lv S; Jayawardana T; Koentgen S; Xu S; Wan Z; Chen Y; Xu H; Shen S; Zhang F; Yang Y; Hold G; He F; El-Omar EM; Yu G; Chen X, 2025, 'Gut microbial-derived 3,4-dihydroxyphenylacetic acid ameliorates reproductive phenotype of polycystic ovary syndrome', Imeta, 4, http://dx.doi.org/10.1002/imt2.70065

Schulz C; Liou JM; Alboraie M; Bornschein J; Nunez CC; Coelho LG; Quach DT; Fallone CA; Chen YC; Gerhard M; Gisbert JP; Jung HY; Katelaris PH; Kim JG; Lu H; Macke L; Mahachai V; Moss SF; Troche JMR; Riquelme A; Romano M; Setshedi M; Smith S; Suerbaum S; Tshibangu-Kabamba E; Vilaichone RK; Yadegar A; Yamaoka Y; Mégraud F; El-Omar EM; Sugano K; Malfertheiner P, 2025, 'Helicobacter pylori antibiotic resistance: a global challenge in search of solutions', Gut, 74, pp. 1561 - 1570, http://dx.doi.org/10.1136/gutjnl-2025-335523

So SHS; Jiang W; Li Y; Hold GL; Goodrick K; Min A; Bourke MJ; El-Omar EM; Jiang XT; Yim HCH, 2025, 'Mucosal DNA and RNA virome alterations and their interactions with human RNA and microRNA transcriptomes in colorectal polyps', Egastroenterology, 3, http://dx.doi.org/10.1136/egastro-2025-100194

Grant-St James A; Lee AC; Lee AJ; Wist J; Sohel F; Wong KW; Yeap BB; Loo RL; Henry A; Susic D; El-Omar E; Nicholson JK; Holmes E; Whiley L; Gray N, 2025, 'Analytical quality control in targeted lipidomics: Evaluating the performance of commercial plasma as a surrogate for pooled study samples', Analytica Chimica Acta, 1365, http://dx.doi.org/10.1016/j.aca.2025.344225

Back to profile page